Overview
- Testifying to the Senate, Susan Monarez said HHS Secretary Robert F. Kennedy Jr. demanded she preapprove upcoming ACIP recommendations and dismiss career CDC vaccine officials without cause; HHS has denied seeking rubber‑stamped decisions while acknowledging firing directives.
- The ACIP meeting scheduled for Sept. 18–19 will consider recommendations on COVID‑19, hepatitis B and other vaccines, with reporting indicating the panel may weigh delaying or removing the newborn hepatitis B birth dose.
- Kennedy removed all 17 ACIP members in June and installed a new slate that includes figures who have questioned vaccine safety, raising concerns about the rigor of impending votes.
- With the CDC directorship vacant after Monarez’s ouster, HHS Deputy Secretary Jim O’Neill is serving as acting director and will be responsible for deciding whether to adopt any ACIP recommendations.
- Committee Chair Bill Cassidy voiced concern over weakening hepatitis B guidance and signaled he will seek Kennedy’s testimony, while Monarez and former CMO Debra Houry warned that politicized vetting of CDC science risks a resurgence of preventable diseases.